Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 3,500 peer-reviewed publications. The CPRD bibliography listed below is updated on a monthly basis (last updated 8 May 2024).

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: CPRD bibliography PDF March 2024 (PDF, 4.2MB, 313 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

Page last reviewed
Year Title Sort descending
2017

Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study

10.1136/bmjopen-2016-013851

Authors: M. Danese, M. Gleeson, L. Kutikova, R. Griffiths, K. Khunti, S. Seshasai, K. Ray

2014

Managing cancer pain at the end of life with multiple strong opioids: a population-based retrospective cohort study in primary care

10.1371/journal.pone.0079266

Authors: W. Gao, M. Gulliford, M. Bennett, F. Murtagh, I. Higginson

2017

Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care-based cohort study, with economic assessment of patient outcomes

10.1111/dom.12867

Authors: J. Gordon, P. McEwan, M. Evans, J. Puelles, A. Sinclair

2022

Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case-control studies

10.3399/bjgp.2022.0137

Authors: M. Abo-Tabik, R. Parisi, C. Morgan, S. Willis, C. Griffiths, D. Ashcroft

2022

Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case-control studies

10.3399/bjgp.2022.0137

Authors: M. Abo-Tabik, R. Parisi, C. Morgan, S. Willis, C. Griffiths, D. Ashcroft

2022

Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum

10.1177/13524585221094218

Authors: M. Leung, M. Bazelier, P. Souverein, B. Uitdehaag, O. Klungel, H. Leufkens, R. Pajouheshnia

2023

Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK

10.1136/bmjopen-2022-068718

Authors: S. Lee, H. Hope, D. O'Reilly, L. Kent, G. Santorelli, A. Subramanian, N. Moss, A. Azcoaga-Lorenzo, A. Fagbamigbe, C. Nelson-Piercy, C. Yau, C. McCowan, J. Kennedy, K. Phillips, M. Singh, M. Mhereeg, N. Cockburn, P. Brocklehurst, R. Plachcinski, R. Riley, S. Thangaratinam, S. Brophy, S. Sudasinghe, U. Agrawal, Z. Vowles, K. Abel, K. Nirantharakumar, M. Black, K. Eastwood

2018

Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring

10.2147/clep.s180618

Authors: K. Hagberg, A. Robijn, S. Jick

2016

Maternal Pre-pregnancy Body Mass Index and Autism Spectrum Disorder among Offspring: A Population-Based Case-Control Study

10.1111/ppe.12306

Authors: K. Getz, M. Anderka, M. Werler, S. Jick

2010

Measles in the United Kingdom 1990-2008 and the effectiveness of measles vaccines

10.1016/j.vaccine.2010.04.084

Authors: H. Jick, K. Hagberg

2007

Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases

Authors: K. Jordan, A. Clarke, D. Symmons, D. Fleming, M. Porcheret, U. Kadam, P. Croft

2014

Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation

10.1002/pds.3631

Authors: L. Huiart, C. Ferdynus, S. Dell'Aniello, N. Bakiri, R. Giorgi, S. Suissa

2019

Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases

10.2147/clep.s181242

Authors: J. Rassen, D. Bartels, S. Schneeweiss, A. Patrick, W. Murk

2020

Measuring the complexity of general practice consultations: a Delphi and cross-sectional study in English primary care

10.3399/bjgp.2020.0486

Authors: C. Salisbury, S. Lay-Flurrie, C. Bankhead, A. Fuller, M. Murphy, B. Caddick, J. Ordonez-Mena, T. Holt, B. Nicholson, R. Perera, F. Hobbs

2020

Measuring the impact of national guidelines: What methods can be used to uncover time-varying effects for healthcare evaluations?

10.1016/j.socscimed.2020.113021

Authors: S. Price, X. Zhang, A. Spencer

2017

Measuring the impact of product withdrawals and other major pharmacovigilance actions on public health burden in the EU: Methodological considerations

Authors: S. Lane, E. Lynn, S. Shakir

2003

Medical conditions as risk factors for pressure ulcers in an outpatient setting

Authors: D. Margolis, J. Knauss, W. Bilker, M. Baumgarten

2004

Medical conditions associated with venous leg ulcers

Authors: D. Margolis, J. Knauss, W. Bilker

2004

Medical event profiling of COPD patients

10.1002/pds.931

Authors: A. Hansell, K. Lam, S. Richardson, G. Visick, J. Soriano

2000

Medical events and resource utilisation in cancer-pain patients treated with strong opioids: an analysis of the UK General Practice Research Database

Authors: P. Tooley, R. Cookson, M Jones, G. Nuyts

2003

Medical outcome of pregnancy in women with psychotic disorders and their infants in the first year after birth

Authors: L. Howard, C. Goss, M. Leese, G. Thornicroft

2018

Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD)

10.1093/rheumatology/key155

Authors: Lejm Scheepers, A. Burden, I. Arts, B. Spaetgens, P. Souverein, F. de Vries, A. Boonen

2019

Medication Use Quality and Safety in Older Adults: 2018 Update

10.1111/jgs.16243

Authors: N. Ailabouni, Z. Marcum, K. Schmader, S. Gray

2021

Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results

10.3310/hta25510

Authors: K. Wing, E. Williamson, J. Carpenter, L. Wise, S. Schneeweiss, L. Smeeth, J. Quint, I. Douglas

2019

Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases

10.1016/s0140-6736(19)31674-5

Authors: H. Strongman, S. Gadd, A. Matthews, K. Mansfield, S. Stanway, A. Lyon, I. dos-Santos-Silva, L. Smeeth, K. Bhaskaran

2021

Menopausal hormone therapy and risk of biliary tract cancers

10.1002/hep.32198

Authors: S. Jackson, R. Pfeiffer, C. Gabbi, L. Anderson, S. Gadalla, J. Koshiol

2012

Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis

10.1002/ijc.26236

Authors: J. Green, G. Czanner, G. Reeves, J. Watson, L. Wise, A. Roddam, V. Beral

2022

Menopausal Hormone Therapy Formulation and Breast Cancer Risk

10.1097/aog.0000000000004723

Authors: H. Abenhaim, S. Suissa, L. Azoulay, A. Spence, N. Czuzoj-Shulman, T. Tulandi

2016

Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink

10.1002/ijc.29960

Authors: K. McGlynn, K. Hagberg, J. Chen, M. Braunlin, B. Graubard, N. Suneja, S. Jick, V. Sahasrabuddhe

2010

Menopause-related workload in general practice 1996-2005: a retrospective study in the UK

10.1093/fampra/cmq038

Authors: L. Iversen, E. Delaney, P. Hannaford, C. Black

2022

Mental Health Morbidities and Time to Cancer Diagnosis Among Adults With Colon Cancer in England

10.1001/jamanetworkopen.2022.38569

Authors: Benitez Majano, G. Lyratzopoulos, N. de Wit, B. White, B. Rachet, C. Helsper, J. Usher-Smith, C. Renzi

2016

Metabolic syndrome in relation to Barrett\textquoterights esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink

10.1016/j.canep.2016.02.008

Authors: J. Drahos, L. Li, S. Jick, M. Cook

2017

Metabolic syndrome in relation to risk of meningioma

10.18632/oncotarget.13667

Authors: C. Seliger, C. Meier, C. Becker, S. Jick, M. Proescholdt, U. Bogdahn, P. Hau, M. Leitzmann

2020

Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study

10.1016/j.jcte.2020.100225

Authors: Y. Tang, T. Weiss, J. Liu, S. Rajpathak, K. Khunti

2014

Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus

10.1503/cmaj.140688

Authors: J. Fournier, H. Yin, O. Yu, L. Azoulay

2011

Metformin and the incidence of prostate cancer in patients with type 2 diabetes

10.1158/1055-9965.epi-10-0940

Authors: L. Azoulay, S. Dell'Aniello, B. Gagnon, M. Pollak, S. Suissa

2017

Metformin and the incidence of viral associated cancers in patients with type 2 diabetes

10.1002/ijc.30733

Authors: B. Hicks, H. Yin, L. Sinyavskaya, S. Suissa, L. Azoulay, P. Brassard

2013

Metformin and the risk of endometrial cancer: a case-control analysis

10.1016/j.ygyno.2013.03.009

Authors: C. Becker, S. Jick, C. Meier, M. Bodmer

2014

Metformin and the risk of head and neck cancer: a case-control analysis

10.1111/dom.12351

Authors: C. Becker, S. Jick, C. Meier, M. Bodmer

2017

Metformin and the risk of renal cell carcinoma: a case-control analysis

10.1097/cej.0000000000000246

Authors: C. Becker, S. Jick, C. Meier, M. Bodmer

2014

Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial

10.2337/dc14-0584

Authors: K. Tsilidis, D. Capothanassi, N. Allen, E. Rizos, D. Lopez, K. van Veldhoven, C. Sacerdote, D. Ashby, P. Vineis, I. Tzoulaki, J. Ioannidis

2012

Metformin does not alter the risk of lung cancer: a case-control analysis

10.1016/j.lungcan.2012.08.010

Authors: M. Bodmer, C. Becker, S. Jick, C. Meier

2015

Metformin initiation and renal impairment: a cohort study in Denmark and the UK

10.1136/bmjopen-2015-008531

Authors: C. Christiansen, V. Ehrenstein, U. Heide-J\orgensen, S. Skovbo, H. N\orrelund, H. Sorensen, L. Li, S. Jick

2019

Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models

10.1093/ije/dyz005

Authors: R. Farmer, D. Ford, R. Mathur, N. Chaturvedi, R. Kaplan, L. Smeeth, K. Bhaskaran

2016

Metformin use and survival after colorectal cancer: A population-based cohort study

10.1002/ijc.29720

Authors: U. Menamin, L. Murray, C. Hughes, C. Cardwell

2016

Metformin use and survival from lung cancer: A population-based cohort study

10.1016/j.lungcan.2016.01.012

Authors: U. Menamin, C. Cardwell, C. Hughes, L. Murray

2012

Metformin, other antidiabetic drugs, and risk of Alzheimer\textquoterights disease: a population-based case-control study

10.1111/j.1532-5415.2012.03916.x

Authors: P. Imfeld, M. Bodmer, S. Jick, C. Meier

2018

Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe

10.1002/pds.4416

Authors: M. Cainzos-Achirica, C. Varas-Lorenzo, A. Pottegard, J. Asmar, E. Plana, L. Rasmussen, G. Bizouard, J. Forns, M. Hellfritzsch, K. Zint, S. Perez-Gutthann, M. Pladevall-Vila

2017

Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom

10.1080/13696998.2017.1345747

Authors: M. Danese, M. Gleeson, R. Griffiths, D. Catterick, L. Kutikova

2019

Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database

10.1002/pds.4811

Authors: C. Minassian, R. Williams, W. Meeraus, L. Smeeth, O. Campbell, S. Thomas